Meds Dw

Drug Ordered Route, Dose, Frequency ---------------------------Generic Name Singulair PO, 5mg, Daily

Montelukast sodium Advair 250/50 Inh, 1 puff, BID

Classification ---------------------------------Possible Routes of Administration Selective competitive Leukotriene receptor antagonist PO Bronchodilator

Usual Dosage

Actions and Uses For Your Patient

Major Side Effects

Nursing Implications

5mg daily

Asthma:Reduces Bronchoconstriction

Assess patient’s underlying conditions and monitor patient for effectiveness; do not abruptly stop

250/50 1 puff BID for patients twelve and older

Long term maintenance of asthma: selectively activates beta 2 receptors, resulting in bronchodilation

Fever, Headache, Fatigue, Dizziness, Dyspepsia, Rash Tachycardia, nasopharyngitis URI

Salmeterol xinafoate 50mcg and fluticasone proprionate 250mcg

Inhalant

Claritin 10mg, PO, daily

Antihistamines

10mg daily

Syrup, Tablets, Rapidly disintegrating tablets Vitamin

Upper respiratory allergies: blocks affects of histamine at H1 receptor sites

0.4mg-1mg daily

Sickle cell anemia: stimulates normal EPO production and nucleoprotein synthesis

Loratidine Folic acid PO, 1mg, Daily

Injection, Tablets

Lifethreatening: Bronchospasm, ventricular arrythmias Headache,drow siness, fatigue , insomnia, nervousness, dry mouth Malaise, confusion, difficulty concentrating, irritation, GI upset LifeThreatening Bronchospasm

1

Drug not indicated for acute bronchospasm; Monitor for rash

Stop drug 4 days before patient undergoes diagnostic skin tests

Advise of side effects: GI affects at higher doses

IV Rate of Administ ration

Drug Ordered Route, Dose, Frequency ---------------------------Generic Name Pepcid Famotidine PO, 20mg, BID

Classification ---------------------------------Possible Routes of Administration Anti ulcer IV, PO

Usual Dosage

Actions and Uses For Your Patient

Major Side Effects

Nursing Implications

Children 1mg/kg/day divided twice daily up to 40 mg BID

To prevent or treat heartburn: competively inhibits action of histamine at H2 receptor sites of parietal cells; decreasing gastric cell secretion

Headache, dizziness, constipation, diarrhea, taste changes

Assess for abdominal pain: note blood in emesis, stool, or gastric aspirate

Neuropathic pain related to SC: unknown pathophysiology

Fatigue, somnolence, dizziness, ataxia

Give at bedtime to minimize drowsiness, if drug had to be stopped do so over one week (decrease likelihood of seizures)

Dose: 200 mg PO q4-6h prn; Start: 400 mg PO x1; Max:1200 mg/day

To reduce pain associated with SC: inhibits prostaglandin synthesis

GI Distress, prolonged bleeding time, tinnitus

Check renal and hepatic function periodicallyin patients on long term therapy; Serious GI toxicity, including peptic ulcers and bleeding can occur

17 g/dose pkt and bulk pwdr

Laxative for constipation related to opioid: acts as an osmotic product

Nausea, bloating, cramps, vomiting, abdominal fullness

Mix thoroughly, refrigerate reconstituted mixture; Warn about adverse reactions

38mg/day for DW

Anticonvulsant Neurontin PO, 100mg, BID

25-35 mg/kg/day PO div tid; Maximum 50 mg/kg/day

Gabapentin

PO

950-1330/day for DW

Advil PO, 400mg, Q6 hrs

NSAID

Ibuprofen

PO

Polyethylene Glycol PO, 17gm/1pk, daily

Osmotic Laxative PO

Miralax

2

Life-threatening: anaphylaxis, arrythmias

IV Rate of Administ ration

Drug Ordered Route, Dose, Frequency ---------------------------Generic Name

Classification ---------------------------------Possible Routes of Administration Stimulant laxative

Sennoside PO, 17.2 mg, BID

Usual Dosage

Actions and Uses For Your Patient

Dilaudid

Before giving, determine whether patient has adequate fluid intake exercise and diet; Avoid exposing drug to excessive heat or light Reassess patient’s level of pain at least 15-30 minutes after administration, Give before patient has intense pain, Monitor respiratory and circulatory status and bowel function

Laxative for constipation related to opioid: increases peristalsis

Nausea, abdominal cramps, malabsorption of nutrients, electrolyte imbalance

0.015 mg/kg IV q46h

Moderate to severe pain

Constipation, sedation, clouded sensorium, dizziness, euphoria

Senokot Opioid analgesic

Nursing Implications

1 tsp granules dissolved in water

PO, Suppository

Hydromorphone PCA pump 0.6ml/hr Maintenance 0.1ml PCA 2x hour 0.1ml Clinician bolus

Major Side Effects

0.57mg q 4-6 hr For DW

Lifethreatening: Bradycardia, Respiratory depression, bronchospasm

PO, IM, IV

3

IV Rate of Administ ration

0.6ml/hr